# Trade Mark Journal No.2026/005 30 January 2026

## WO0000001891631 (1,5,42)

Office of origin: Switzerland

Date of International Registration:24 September 2025
Date of designation in the UK: 24 September 2025

International priority date claimed: 29 July 2025 (Switzerland) (836825)

Class 1
  Kits consisting of cell lines, reagents, enzyme substrates and/or chemical preparations genetically modified; reagents, nucleic acids and nucleotides for scientific use and for research purposes in the fields of clinical research, drug development, research in agriculture and genetics; reagent kits consisting of reagents and chemical preparations; samples of nucleotide sequence variants and modifications for use in the field of scientific research, clinical research and scientific research in diagnosis.
Class 5
  Biological preparations for use in clinical and medical cell therapy; Gene therapy products, namely, modified cells and modified cell platforms.
Class 42
  Scientific research and laboratory services in the fields of editing, modification, engineering and regulation of genes, genome and cells for the development of pharmaceutical and biological preparations for human and veterinary use; Aggregation, analysis and provision of data in the field of genomics; custom design and development of cell lines designed for others for scientific research, drug discovery and development; scientific research and laboratory services in the fields of editing, modification, engineering and regulation of genes, genome and cells for the development of medical diagnostic products.

Lonza Ltd.

Representative: Simkins LLP, Lynton House, 7-12 Tavistock Square London WC1H 9LT UNITED KINGDOM